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bstract. In this study, high resolution backward-mode
hotoacoustic microscopy PAM is used to noninvasively
mage progressive extravasation and accumulation of
anoshells within a solid tumor in vivo. PAM takes advan-
age of the strong near-infrared absorption of nanoshells
nd their extravasation tendency from leaky tumor vascu-
atures for imaging. Subcutaneous tumors are grown on
mmunocompetent BALB/c mice. Polyethylene glycol PE-
ylated nanoshells with a peak optical absorption at
800 nm are intravenously administered. With an
00-nm laser source, a prescan prior to nanoshell injec-
ion is taken to determine the background that is free of
anoshell accumulation. After injection, the 3-D
anoshell distribution at the tumor foci is monitored by
AM for 6 h. Experimental results show that accumulated
anoshells delineate the tumor position. Nanoshell accu-
ulation is heterogeneous in tumors: more concentrated
ithin the tumor cortex and largely absent from the tumor
ore. Because nanoshells have been recently demon-
trated to enhance thermal therapy of subcutaneous tu-
ors, we anticipate that PAM will be an important aid
efore, during, and after nanoshell thermal therapy. © 2009
ociety of Photo-Optical Instrumentation Engineers.
DOI: 10.1117/1.3081556
eywords: photoacoustic microscopy; nanoshell extravasation; en-
anced permeability and retention effect.
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Photoacoustic imaging is an emerging noninvasive imag-
ng modality and has been shown to be a promising tool for
isualizing tissue structures and functions by means of laser-
nduced ultrasound.1,2 Structures with high optical absorption,
Address all correspondence to: Lihong V. Wang, Department of Biomedical
ngineering, Washington University in St. Louis, Campus Box 1097, One Brook-
ngs Drive, St. Louis, MO 63130-4899. Tel: 314-935-6152; Fax: 314-935-7448;
mail: lhwang@biomed.wustl.edu.ournal of Biomedical Optics 010507-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usesuch as blood vessels in the visible spectral region, can be
imaged with ultrasound resolution, which is not limited by the
strong optical scattering in biological tissues. Recently, an in-
vivo backward-mode confocal photoacoustic microscope
PAM with dark-field illumination was invented to image
microvasculatures in the skin.3–5 This system offers high lat-
eral resolution 45 m at the focal point, high axial reso-
lution 15 m, and is capable of imaging optical absorp-
tion contrast as deeply as 3 mm. It shows great potential for
applications in dermatology and related cancer research.
Contrast-agent-enhanced optical imaging techniques pos-
sess high sensitivity and specificity. In this study, we use gold
nanoshells AuroShell™ Particles, Nanospectra Biosciences,
Incorporated, Houston, Texas as a contrast agent for photoa-
coustic microscopy of tumors. Gold nanoshells have been ap-
plied to photothermal therapy of subcutaneous murine
tumors6 and have also been used as a contrast agent for in-
vivo brain imaging with photoacoustic tomography, enhancing
contrast of cortex vessels in rat brain.7 Gold nanoshells are a
new type of optically tunable nanoparticles, composed of
silica cores 116 nm in diameter coated with an ultrathin
gold shell 14 nm.8 By adjusting the core size relative to
the thickness of the gold shell, the optical properties of
nanoshells can be varied across a broad range of the electro-
magnetic spectrum that spans the visible and infrared regions.
In our cancer applications, gold nanoshells are designed to
absorb light at near-infrared NIR wavelengths. The peak op-
tical absorption of nanoshells in this study is at a wavelength
of 800 nm that corresponds to optimal penetration into
scattering biological tissues, and is the isosbestic point of the
molar extinction spectra of oxy- and deoxyhemoglobin, thus
reducing the effect of blood oxygenation variations on pho-
toacoustic signals.7 Nanoshells tend to preferentially extrava-
sate from leaky tumor vasculatures and accumulate in
tumors—a preferential, size- and shape-dependent
accumulation—via the enhanced permeability and retention
effect due to their nanoscale size i.e., passive targeting.9–11
The end result of nanoshell accumulation is greatly enhanced
NIR optical absorption contrast in the vicinity of tumor vas-
culatures. In addition, the gold nanoshells used in this study
were coated with 5-kD polyethylene glycol PEG to increase
their circulation time in the blood stream. The PEGylated
nanoshells were measured to have a half-life of 3.7 h in the
blood stream of immunocompetent BALB/c mice.7
In this study, the PAM was used to noninvasively image
the progressive extravasation of gold nanoshells through solid
tumor vasculature in vivo. High resolution and high contrast
3-D gold nanoshell distribution at the solid tumor foci was
imaged for 6 h. This technology allows us to monitor the
dynamics of nanoshells in the solid tumor without any inva-
sive biological modification such as the use of a dorsal skin-
fold window chamber.9
Figure 1 shows the experimental setup of a photoacoustic
microscope for in-vivo imaging of nanoshell extravasation in
solid tumors. A tunable Ti:sapphire laser LT-2211A, Lotis
TII pumped by a Nd:YAG laser LS-2137/2, Lotis TII was
employed to provide pulses with a pulse width of 15 ns, a
pulse repetition rate of 10 Hz, and a wavelength of 800 nm,
the peak optical absorption wavelength of the nanoshells used
1083-3668/2009/141/010507/3/$25.00 © 2009 SPIEJanuary/February 2009  Vol. 1411
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
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Downloaded Fron this study. The laser energy was delivered by a multimode
ber with a 0.6 mm diameter. The fiber tip was coaxially
ositioned on a 3-D precision mechanical scanner. An axicon
nd a mirror were used to form dark-field illumination and
ake the light confocal with a 50-MHz focused ultrasonic
ransducer V214-BC-RM, Panametrics, whose fractional
andwidth is 70%. The incident energy density on the sample
urface was controlled to 2 mJ /cm2, which is well within
he ANSI standards. A homemade concave lens provided this
ransducer with a numerical aperture of 0.44 and a focal
ength of 6.7 mm, offering a lateral resolution of 45 m and
n axial resolution of 15 m. The lens was ground from the
ermanent fused-silica delay line attached to the transducer.
he transducer was immersed in a water tank, which had a
ole at the bottom sealed with a piece of polyethylene mem-
rane. The imaged part of the animal e.g., the head of the
ouse was coated with a thin layer of ultrasonic gel and then
laced below the membrane. The photoacoustic signals re-
eived by the ultrasonic transducer were amplified and re-
orded by a digital oscilloscope TDS 5034B, Tektronix at a
50-MHz sampling rate. Note that the photoacoustic images
hown were taken without signal averaging, and the bright-
ess of the images represents the amplitude of the detected
hotoacoustic signals.
Immunocompetent BALB/c mice weighing about 20 g
ere used for the in-vivo experiments. All of the experimental
nimal procedures were approved by the University Labora-
ory Animal Care Committee of Texas A&M University. The
ice were inoculated with CT26.wt murine colon carcinoma
ells subcutaneously on the heads. The mouse head was a
ood model for long-term immobilization required in our ex-
eriments. Imaging was performed 7 days after tumor inocu-
ation and under isoflurane gas anesthesia with a dose of 1%
n pure oxygen at a 1-L /min flow rate. We maintained the
emperature of the imaged tumor region at 39 °C by control-
ing the temperature of the water in the tank.9,12 The body
emperature of the animal was maintained by using a water
eating pad and a lamp; the pulse rate and arterial blood oxy-
enation were monitored using a pulse oximeter model 8600,
onin Medical, Incorporated clamped on the back paw. A
rescan prior to nanoshell administration was performed
o determine the background signal. PEGylated nanoshells
ith a peak optical absorption at 800 nm were then
ntravenously administered. The nanoshell dose was
bout 1.4109-nanoshells /g body weight 1.8
ig. 1 Schematic of the photoacoustic microscope for nanoshell im-
ging: Ti:Sa, Ti:sapphire.ournal of Biomedical Optics 010507-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Use1010 nanoshells /ml blood. At this concentration, the ab-
sorption coefficient due to nanoshells is 7 cm−1 at 800 nm.
In comparison, the absorption coefficient of whole blood at
800 nm is 4 cm−1. After injection, the 3-D nanoshell distri-
bution at the tumor foci was monitored by PAM for 6 h. After
imaging, the mice were sacrificed using pentobarbital over-
dose 120 mg /kg, IP. The imaged tumor and surrounding
tissue were excised and stained with hematoxylin and eosin
HE for histology.
PAM measurements illustrate the passive uptake of
nanoshells at the inoculated tumor foci. Figures 2a, 2c,
2e, and 2g are maximum-amplitude-projected MAP im-
ages taken prior to and at 1.4, 3, and 5.8 h postnanoshell
injection, respectively. In the MAP images, the maximum
value of the photoacoustic signal of each A-line along the
depth direction versus the 2-D transducer position is plotted.
The images are shown on the same grayscale. It is shown in
Fig. 2a that without nanoshell injection, the intrinsic blood
absorption contrast is relatively low. The nanoshells increase
the signal amplitudes from blood vessels by a factor of 2,
thus, enhancing the contrast of blood vessels. With the help of
nanoshells, Figs. 2c, 2e, and 2g show the feeding vessels
and accumulated nanoshells at tumor foci well. The nanoshell
accumulation gradually delineates the tumor contour and po-
Fig. 2 In-vivo noninvasive photoacoustic images of nanoshell ex-
travasation from solid tumor vasculature. a, c, e, and g show
in-vivo maximum-amplitude-projected MAP images acquired prior
to nanoshell administration and at 1.4, 3, and 5.8 h postnanoshell
administration, respectively. The horizontal and vertical axes indicate
the scanning position of the acoustic transducer. b, d, f, and h
show in-vivo B-scan images that correspond to the scanning position
indicated by the white dashed line in c and are acquired before and
at 1.4, 3, and 5.8 h after nanoshell injection, respectively. The vertical
axis is the imaging depth and the horizontal axis is the lateral scan-
ning position. In d, the dash-dotted line is the depth of skull; T is
tumor; V is vessel; and arrow is nanoshell.January/February 2009  Vol. 1412
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
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Downloaded Froition, which cannot be visualized without nanoshells.
Figures 2b, 2d, 2f, and 2h show the B-scan images,
f which the scanning position corresponds to the white
ashed line in Fig. 2c, and are acquired before and at 1.4, 3,
nd 5.8 h after nanoshell injection, respectively. The images
re shown on the same grayscale. The brightness represents
he photoacoustic pressure amplitude detected by the trans-
ucer. In the B-scan images, the vertical axis is the depth and
he horizontal axis is the lateral scanning position. In Fig.
d, the character “T” marks the tumor core position; the
haracter “V” indicates the depth of one feeding vessel of the
umor. The bright spots in Figs. 2d, 2f, and 2h, at the
ositions indicated by the arrows in Fig. 2d, are the photoa-
oustic signals from accumulated nanoshells. These B-scan
mages reveal the depth information where nanoshells accu-
ulate, which also indicate that the nanoshells distribute
ainly around the tumor cortex. Similar results were ob-
erved on several mice. Most signals shown below the dash-
otted line i.e., skull position in Fig. 2d are skull-reflected
hotoacoustic signals.
Absence of nanoshells within the tumor core is observed in
igs. 2d, 2f, and 2h. We show that nanoshell accumula-
ion is heterogeneous in tumors: largely absent from the tumor
ore and more concentrated within the tumor cortex, as shown
n literature.12,13 The difficulties in delivery of nanoparticles
ithin tumor cores are possibly caused by both the high in-
erstitial pressure and the avascularity of necrotic tumor
ores.12–14
Time-dependent variation of absorption in the vessels and
umor foci attributable to the injected nanoshells can be ob-
erved via changes in photoacoustic signals. Figure 3 shows
he averaged photoacoustic signals at vessels and tumor foci
n the MAP images of Fig. 2, respectively, as a function of
ime. The results show the clearance and accumulation pro-
les of the nanoshells in vessels and tumor regions, respec-
ively: nanoshells in the vessels are gradually cleared out by
he reticuloendothelial system of the mouse, and those in the
umor foci are progressively taken up, owing to poor lym-
hatic drainage of the tumor i.e., the enhanced permeability
nd retention effect. At 5.8 h after nanoshell injection, the
ontrast ratio of the tumor foci to the vessels is 6.5.
ig. 3 Averaged photoacoustic signals as a function of time. Line with
ircles: vessel regions; dashed line with squares: tumor foci. 0 h rep-
esents “prior to nanoshell injection.” Error bar represents plus and
inus one standard deviation.ournal of Biomedical Optics 010507-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of UseIn summary, by employing PAM, we successfully image
extravasation of gold nanoshells from solid tumor vasculature
in vivo. Using exogenous contrast from nanoshells, image
contrast is significantly enhanced at 800 nm, whether it is
vessels or tumor foci. It is also found that nanoshell accumu-
lation is heterogeneous in tumors. Because gold nanoshells
have been recently applied to photothermal therapy for sub-
cutaneous tumors, we anticipate that the integration of PAM
into gold-nanoshell-based photothermal therapy to character-
ize and monitor the accumulation of gold nanoshells in solid
tumors would be an invaluable aid.6,7 In addition, by using
bioconjugated gold nanoshells that target specific molecular
signatures of disease, the technique presented here i.e., PAM
plus nanoshells can potentially enable molecular imaging.15
Acknowledgments
We are grateful to Gina Lungu and Ovidiu Cracium for their
assistance with cell culture and veterinary procedure, and to
Jung-Taek Oh, Hao F. Zhang, and Konstantin Maslov for their
technical advice and prior system development. This project is
sponsored in part by the National Institutes of Health grants
R01 EB000712 and R01 NS46214, and in part by the Ad-
vanced Technology Program at NIST, cooperative agreement
70NANB4H3040.
References
1. M. Xu and L. V. Wang, “Photoacoustic imaging in biomedicine,” Rev.
Sci. Instrum. 77, 041101-1–041101-22 2006.
2. L. V. Wang, “Ultrasound-mediated biophotonic imaging: a review of
acousto-optical tomography and photoacoustic tomography,” Dis.
Markers 19, 123–138 2004.
3. K. Maslov, G. Stoica, and L. V. Wang, “In vivo dark-field reflection-
mode photoacoustic microscopy,” Opt. Lett. 30, 625–627 2005.
4. M.-L. Li, H. F. Zhang, K. Maslov, G. Stoica, and L. V. Wang, “Im-
proved in vivo photoacoustic microscopy based on a virtual-detector
concept,” Opt. Lett. 31, 474–476 2006.
5. H. F. Zhang, K. Maslov, G. Stoica, and L. V. Wang, “Functional
photoacoustic microscopy for high resolution and noninvasive in vivo
imaging,” Nat. Biotechnol. 24, 848–851 2006.
6. D. P. O’Neal, L. R. Hirsch, N. J. Halas, J. D. Payne, and J. L. West,
“Photo-thermal tumor ablation in mice using near infrared-absorbing
nanoparticles,” Cancer Lett. 209, 171–176 2004.
7. Y. Wang, X. Xie, X. Wang, G. Ku, K. L. Gill, D. P. O’Neal, G. Stoica,
and L. V. Wang, “Photoacoustic tomography of a nanoshell contrast
agent in the in vivo rat brain,” Nano Lett. 4, 1689–1692 2004.
8. S. J. Oldenburg, J. B. Jackson, S. L. Westcott, and N. J. Halas, “In-
frared extinction properties of gold nanoshells,” Appl. Phys. Lett. 75,
2897–2899 1999.
9. G. Kong, R. D. Braun, and M. W. Dewhirst, “Characterization of the
effect of hyperthermia on nanoparticle extravasation from tumor vas-
culature,” Cancer Res. 61, 3027–3032 2001.
10. X. Gao, Y. Gui, R. M. Levenson, L. W. K. Chung, and S. Nie, “In
vivo cancer targeting and imaging with semiconductor quantum
dots,” Nat. Biotechnol. 22, 969–976 2004.
11. P. Decuzzi, R. Pasqualini, W. Arap, and M. Ferrari, “Intravascular
delivery of particulate systems: does geometry really matters?,”
Pharm. Res. 26, 235–243 2009.
12. P. Liu, A. Zhang, Y. Xu, and X. Xu, “Study of non-uniform micro-
particle liposome extravasation in tumour,” Int. J. Hyperthermia 21,
259–270 2005.
13. R. Jain, “Transport of molecules, particles, and cells in solid tumors,”
Annu. Rev. Biomed. Eng. 1, 241–263 1999.
14. T. P. Padera, B. R. Stoll, J. B. Tooredman, D. Capen, E. di Tomaso,
and R. K. Jain, “Pathology: cancer cells compress intratumour ves-
sels,” Nature (London) 427, 695 2004.
15. C. Loo, L. Hirsch, M. H. Lee, E. Chang, J. West, N. Halas, and R.
Drezek, “Gold nanoshell bioconjugates for molecular imaging in liv-
ing cells,” Opt. Lett. 30, 1012–1014 2005.January/February 2009  Vol. 1413
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
